– Deal to add navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst’s HAE portfolio – – Solidifies double digit growth trajectory for HAE portfolio over the next decade – – BioCryst expects to remain profitable (non-GAAP) and cash flow positive post-transaction – – Implied aggregate equity-value of approximately $920 million and implied enterprise...

Investment manager giant BlackRock, Inc. ( BLK ) reported that third-quarter 2025 revenue grew 25% year-over-year (Y/Y) to $6.51 billion, beating the consensus of $6.22 billion.  Adjusted operating income rose 23% Y/Y to $2.62 billion. Adjusted EPS increased 1% Y/Y to $11.55, beating the consensus of $11.26. Revenue and Profit Breakdown Investment advisory, administration fees, and securities lending revenue increased to $5.05 billion from $4.03 billion a year ago. Also Read: BlackRock’s GIP In Talks To Acquire Aligned Data Centers In $40...

07:01 AM EDT, 10/14/2025 (MT Newswires) -- Nova Minerals ( NVA ) said Tuesday it has briefed Australian Ambassador to the United States Kevin Rudd on its Estelle Gold and Critical Minerals Project in Alaska as part of preparations for the Oct. 20 meeting between Australian Prime Minister Anthony Albanese and US President Donald Trump in Washington, D.C. Nova Minerals...

07:01 AM EDT, 10/14/2025 (MT Newswires) -- BP (BP) said in a regulatory filing on Tuesday that it now expects upstream output to be higher in Q3 compared with the prior quarter. That compares with the oil and gas giant's August forecast of slightly lower upstream production in Q3 compared with Q2. BP also said it expects higher output in...